|
MechanismDYRK1A inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with AItenea Biotech S.L.
0 Patents (Medical) associated with AItenea Biotech S.L.
100 Deals associated with AItenea Biotech S.L.
100 Translational Medicine associated with AItenea Biotech S.L.